Aggregated News
STEM cell research, we have long been told, should pave the way for revolutionary new treatments to help millions of patients around the world.
Yet despite the years of study and debate about the potential, therapies have been slow to materialise.
Even the head of the UK National Stem Cell Network has now conceded that stem cell research may never deliver new treatments.
Given the ethical controversy about the research - particularly the use of animal-human hybrid embryos - some have questioned whether it is worth pursuing the research any further without proof that it will actually benefit human health.
But researchers meeting in Edinburgh later this week for the first ever UK National Stem Cell Research Conference will very much be spreading the message that the science is producing results and experts must be allowed to continue to study stem cells in their many forms.
Lord Patel of Dunkeld, chairman of the UK National Stem Cell Network and chancellor of Dundee University, said the current signs were that research involving stem cells would lead to therapies for patients.
But...
Yet despite the years of study and debate about the potential, therapies have been slow to materialise.
Even the head of the UK National Stem Cell Network has now conceded that stem cell research may never deliver new treatments.
Given the ethical controversy about the research - particularly the use of animal-human hybrid embryos - some have questioned whether it is worth pursuing the research any further without proof that it will actually benefit human health.
But researchers meeting in Edinburgh later this week for the first ever UK National Stem Cell Research Conference will very much be spreading the message that the science is producing results and experts must be allowed to continue to study stem cells in their many forms.
Lord Patel of Dunkeld, chairman of the UK National Stem Cell Network and chancellor of Dundee University, said the current signs were that research involving stem cells would lead to therapies for patients.
But...